<生产厂家价格>

乌苯美司

乌苯美司用途

Bestatin是一种天然,广谱,竞争性的氨肽酶抑制剂。

乌苯美司名称

[ CAS 号 ]:
58970-76-6

[ 中文名 ]:
乌苯美司

[ 英文名 ]:
Ubenimex

[中文别名 ]:

贝他定

[英文别名 ]:

BESTATIN
BENIMEX
Bestatin,UbeniMex
nk421
MFCD00083262
N-(3-Amino-2-hydroxy-4-phenylbutanoyl)leucine
EINECS 261-529-2

乌苯美司生物活性

[ 描述 ]:

Bestatin是一种天然,广谱,竞争性的氨肽酶抑制剂。

[ 相关类别 ]:

信号通路 >> 代谢酶/蛋白酶 >> 氨肽酶

研究领域 >> 癌症

[体外研究]

Bestatin增强ATRA诱导的分化并抑制ATRA驱动的ATRA敏感的APL NB4细胞中p38 MAPK的磷酸化。 Bestatin不能逆转ATRA抗性APL MR2细胞中的分化阻滞。 CD13与抗CD13抗体WM-15结合导致p38 MAPK磷酸化,降低Bestatin对p38 MAPK磷酸化的抑制作用,并完全消除了Bestatin对ATRA诱导NB4细胞分化的增强作用[2]。由于细胞生长速率降低和细胞分裂频率降低,Bestatin(600μM)处理的细胞在细胞周期中进展缓慢。 Bestatin抑制D. discoideum中有丝分裂的频率和固有的多核,并且在0-600μM时对D. discoideum细胞没有细胞毒性。 Bestatin抑制PsaA-GFP和GFP表达细胞裂解液中的氨肽酶活性分别为对照的69.39％±10.5％和39.93％±18.7％[4]。

[体内研究]

与糖尿病载体治疗的小鼠相比,Bestatin(20μM)显着降低糖尿病小鼠中的CD13表达并导致MMP-9特异性凝胶分解带密度的显着抑制。 Bestatin治疗显着抑制糖尿病小鼠中VEGF和乙酰肝素酶的表达。玻璃体腔内bestatin治疗显着下调糖尿病小鼠视网膜中HIF-1α和VEGF的表达。此外,玻璃体内bestatin治疗显着抑制了糖尿病小鼠视网膜中乙酰肝素酶的上调表达[1]。在对SRBC的抗原强化的体液应答之前,Bestatin(10,1和0.1mg/kg,ip)处理导致产生溶血性抗SRBC抗体(PFC)和2-ME抗性血清血凝素滴度的脾细胞数量增加。 (剂量为0.1 mg/kg)。注射环磷酰胺后隔天给小鼠服用5次Bestatin(1和0.1 mg/kg)不会改变药物对PFC数量的抑制作用,甚至导致剂量下总抗SRBC血凝素的进一步减少抗原刺激后第7天1 mg/kg [3]。

[激酶实验]

收获细胞，洗涤并在NP-40裂解缓冲液（50mM Tris-HCl [pH 7.5]，150mM NaCl，0.5％NP-40）中裂解。使用Bradford测定法定量总细胞蛋白质，并制备1mg / mL蛋白质等分试样。将10微升总细胞蛋白与290μL底物溶液（0.1mg / mL二硫苏糖醇[DTT]，0.1mg / mL白蛋白和1mM丙氨酸-β-萘酰胺）混合。在15和30分钟后进行荧光测量（340nm激发，400nm发射）。 15和30分钟测量之间的线的斜率用于表示氨肽酶活性。在荧光氨基肽酶测定之前，将总细胞蛋白与bestatin，amastatin，嘌呤霉素，EDTA和/或ZnCl2一起预孵育20分钟。

[细胞实验]

将生长的细胞（1×10 6至2×10 6个细胞/ mL）稀释至1.0×10 3个细胞/ mL，并转移（3mL）到12孔多孔板（2.5cm直径/孔）中的孔中。用0,10,50,100,300或600μMBidatin处理细胞，并使其在21℃下以180rpm振荡培养48小时。血细胞计数器用于在0,24和48小时后测量细胞密度。

[动物实验]

将Bestatin溶解在PBS中。在SRBC免疫之前，将药剂（10,1和0.1mg / kg的剂量）腹膜内注射到非环磷酰胺处理的小鼠中，以24小时间隔注射5或10次。在最后一剂bestatin后24小时免疫小鼠。在SRBC免疫前12天，以350mg / kg的剂量单次腹膜内注射环磷酰胺诱导药理学免疫抑制。在SRBC免疫前，将剂量为1和0.1mg / kg的Bestatin以48小时间隔腹膜内注射环磷酰胺免疫抑制小鼠5次，或以24小时间隔注射10次。在环磷酰胺后24小时施用第一剂bestatin，而在SRBC免疫前24小时注射最后一剂药物。

[参考文献]

[1]. Hossain A, et al. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice. Exp Eye Res. 2016 Aug;149:100-6

[2]. Qian X, et al. Inhibition of p38 MAPK Phosphorylation Is Critical for Bestatin to Enhance ATRA-Induced Cell Differentiation in Acute Promyelocytic Leukemia NB4 Cells. Am J Ther. 2016 May-Jun;23(3):e680-9.

[3]. Lis M, et al. The effects of bestatin on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice. Immunopharmacol Immunotoxicol. 2013 Feb;35(1):133-8

[4]. Poloz Y, et al. Bestatin inhibits cell growth, cell division, and spore cell differentiation in Dictyostelium discoideum. Eukaryot Cell. 2012 Apr;11(4):545-57

[相关活性小分子]

托舍多特 | DG051 | 贝他定盐酸

乌苯美司物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
604.7±55.0 °C at 760 mmHg

[ 熔点 ]:
245 °C (dec.)(lit.)

[ 分子式 ]:
C₁₆H₂₄N₂O₄

[ 分子量 ]:
308.373

[ 闪点 ]:
319.5±31.5 °C

[ 精确质量 ]:
308.173615

[ PSA ]:
112.65000

[ LogP ]:
2.64

[ 外观性状 ]:
白色结晶粉末

[ 蒸汽压 ]:
0.0±1.8 mmHg at 25°C

[ 折射率 ]:
1.557

[ 储存条件 ]:
通风低温干燥,与库房食品原料分开存放

[ 水溶解性 ]:
水溶性：实际上不溶；可溶于：甲醇；不溶：氯仿,苯,乙醇

乌苯美司MSDS

详细MSDS(安全技术说明书)

乌苯美司毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: OH2915000

CHEMICAL NAME :: L-Leucine, N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-, (S-(R*,S*))-

CAS REGISTRY NUMBER :: 58970-76-6

LAST UPDATED :: 199612

DATA ITEMS CITED :: 9

MOLECULAR FORMULA :: C16-H24-N2-O4

MOLECULAR WEIGHT :: 308.42

WISWESSER LINE NOTATION :: 1Y1&1YVQMVYQYZ1R

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD - Lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >2 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 780 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1900 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983

TYPE OF TEST :: LD - Lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >4 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 190 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1300 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983

TYPE OF TEST :: LD - Lethal dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: >1200 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968- Volume(issue)/page/year: 36,2971,1983 ** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 63700 mg/kg/91D-C

TOXIC EFFECTS :: Kidney, Ureter, Bladder - proteinuria

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 27,401,1984 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 1250 mg/kg

SEX/DURATION :: female 16-20 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

REFERENCE :: HMMRA2 Hormone and Metabolic Research. (Georg Thieme Verlag, Postfach 732, D-7000 Stuttgart 1, Fed. Rep. Ger.) V.1- 1969- Volume(issue)/page/year: 21,366,1989

乌苯美司安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危害码 (欧洲) ]:
Xn

[ 安全声明 (欧洲) ]:
S22-S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ RTECS号 ]:
OH2915000

乌苯美司合成路线

详细合成路线

乌苯美司上下游产品

乌苯美司上游产品

乌苯美司下游产品

乌苯美司文献

Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes.

PLoS ONE 7(12) , e51072, (2012)

Chemerin is a leukocyte chemoattractant and adipokine with important immune and metabolic roles. Chemerin, secreted in an inactive form prochemerin, undergoes C-terminal proteolytic cleavage to genera...

Gingipain aminopeptidase activities in Porphyromonas gingivalis.

Biol. Chem. 393(12) , 1471-6, (2012)

Bestatin, a specific inhibitor of metalloaminopeptidases,inhibits the growth of Porphyromonas gingivalis. To identify its target enzyme, a library of fluorescent substrates was used but no metalloamin...

Preparation and evaluation of a new releasable PEGylated tumor necrosis factor-α (TNF-α) conjugate for therapeutic application.

Sci. China Life Sci. 56(1) , 51-8, (2013)

To design a releasable PEGylated TNF-α (rPEG-TNF-α), a cathepsin B-sensitive dipeptide (Val-Cit moiety) was inserted into conventional PEG-modified TNF-α (PEG-TNF-α), facilitating its clinical use for...

更多文献